Hepion Pharmaceuticals Inc

General ticker "HEPA" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $4.1M

Hepion Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -38.1%.

Estimated limits based on current volatility of 5.3%: low 0.48$, high 0.54$

Factors to consider:

  • Current price 72.8% below estimated low
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.84$, 5.69$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.85$, 5.05$]

Financial Metrics affecting the HEPA estimates:

  • Negative: Non-GAAP EPS, $ of -14.78 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -75.29 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85

Similar symbols

Short-term HEPA quotes

Long-term HEPA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $30.40MM $45.49MM $48.45MM
Operating Income $-30.40MM $-45.49MM $-48.45MM
Non-Operating Income $-2.32MM $0.40MM $-0.89MM
Interest Expense $0.01MM $0.01MM $0.01MM
R&D Expense $20.40MM $33.27MM $35.64MM
Income(Loss) $-32.72MM $-45.08MM $-49.34MM
Taxes $0.00MM $-2.88MM $-0.41MM
Profit(Loss) $-32.72MM $-42.20MM $-48.93MM
Stockholders Equity $93.00MM $49.86MM $7.28MM
Assets $103.55MM $60.24MM $18.09MM
Operating Cash Flow $-31.22MM $-34.96MM $-40.89MM
Capital expenditure $0.13MM $0.02MM $0.01MM
Investing Cash Flow $-0.13MM $-0.01MM $-0.01MM
Financing Cash Flow $81.98MM $-5.14MM $4.49MM
Earnings Per Share* $-9.31 $-11.07 $-12.32

* EPS are Split Adjusted, recent splits may be reflected with a delay.